The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Down‐regulation of BRCA1 expression by miR‐146a and miR‐146b‐5p in triple negative sporadic breast cancers
Open accessAbstract
Germ-line mutations in the BRCA1 gene strongly predispose women to breast cancer (lifetime risk up to 80%). Furthermore, the BRCA1 protein is absent or present at very low levels in about one third of sporadic breast cancers. However, the mechanisms underlying BRCA1 somatic inactivation appear multiple and are still not fully understood. We report here the involvement of miR-146a and miR-146b-5p that bind to the same site in the 3'UTR of BRCA1 and down-regulate its expression as demonstrated using reporter assays. This was further confirmed with the endogenous BRCA1 gene by transfecting microRNA (miRNA) precursors or inhibitors in mammary cell lines. This down-regulation was accompanied by an increased proliferation and a reduced homologous recombination rate, two processes controlled by BRCA1. Furthermore, we showed that the highest levels of miR-146a and/or miR-146b-5p are found in basal-like mammary tumour epithelial cell lines and in triple negative breast tumours, which are the closest to tumours arising in carriers of BRCA1 mutations. This work provides further evidence for the involvement of miRNAs in sporadic breast cancer through down-regulation of BRCA1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Miranda, K. C., Huynh, T., Tay, Y., Ang, Y.-S., Tam, W.-L., Thomson, A. M., Lim, B., & Rigoutsos, I. (2006) · Cell · doi:10.1016/j.cell.2006.07.031 · Cited by 2,063
Hallmarks of 'BRCAness' in sporadic cancers
Turner, N., Tutt, A., & Ashworth, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1457 · Cited by 1,657
XRCC3 promotes homology-directed repair of DNA damage in mammalian cells
Pierce, A. J., Johnson, R. D., Thompson, L. H., & Jasin, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2633 · Cited by 1,379
A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors
Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J. M., Stoop, H., Nagel, R., Liu, Y.-P., van Duijse, J., Drost, J., Griekspoor, A., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.037 · Cited by 1,264
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Esteller, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.564 · Cited by 1,233 · cited 3×
“In a fraction of these tumours, this low BRCA1 expression could be due to 2011 EMBO Molecular Medicine 279 280 aberrant methylation of the promoter, which was reported in 11–14% of breast cancer cases (Catteau et al, 1999; Esteller et al, 2000; Rice et al, 2000; Turner et al, 2007).”
BackgroundThe role of microRNA genes in papillary thyroid carcinoma
He, H., Jazdzewski, K., Li, W., Liyanarachchi, S., Nagy, R., Volinia, S., Calin, G. A., Liu, C.-G., Franssila, K., Suster, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509603102 · Cited by 1,215
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., Qian, D., Diehn, M., Liu, H., Panula, S. P., Chiao, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.07.011 · Cited by 1,213
(2005) · doi:10.1093/nar/gki200 · Cited by 1,208
Basal-Like Breast Cancer: A Critical Review
Rakha, E. A., Reis-Filho, J. S., & Ellis, I. O. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1748 · Cited by 1,164
Untranslated regions of mRNAs.
(2002) · Genome biology · doi:10.1186/gb-2002-3-3-reviews0004 · Cited by 987
Pauley, K. M., Satoh, M., Chan, A. L., Bubb, M. R., Reeves, W. H., & Chan, E. K. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2493 · Cited by 766
MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?
Sonkoly, E., Wei, T., Janson, P. C. J., Sääf, A., Lundeberg, L., Tengvall-Linder, M., Norstedt, G., Alenius, H., Homey, B., Scheynius, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000610 · Cited by 754
Wang, X., Tang, S., Le, S.-Y., Lu, R., Rader, J. S., Meyers, C., & Zheng, Z.-M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002557 · Cited by 741
Expression of microRNA‐146 in rheumatoid arthritis synovial tissue
Nakasa, T., Miyaki, S., Okubo, A., Hashimoto, M., Nishida, K., Ochi, M., & Asahara, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23429 · Cited by 678
Microarray-based, high-throughput gene expression profiling of microRNAs
Nelson, P. T., Baldwin, D. A., Scearce, L. M., Oberholtzer, J. C., Tobias, J. W., & Mourelatos, Z. (2004) · Nature Methods · doi:10.1038/nmeth717 · Cited by 634
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 604
BRCA1 dysfunction in sporadic basal-like breast cancer
Turner, N. C., Reis-Filho, J. S., Russell, A. M., Springall, R. J., Ryder, K., Steele, D., Savage, K., Gillett, C. E., Schmitt, F. C., Ashworth, A., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210014 · Cited by 573
Perry, M. M., Moschos, S. A., Williams, A. E., Shepherd, N. J., Larner-Svensson, H. M., & Lindsay, M. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5689 · Cited by 461
miR-146a Suppresses Invasion of Pancreatic Cancer Cells
Li, Y., VandenBoom, T. G., Wang, Z., Kong, D., Ali, S., Philip, P. A., & Sarkar, F. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2792 · Cited by 421
Hurst, D. R., Edmonds, M. D., Scott, G. K., Benz, C. C., Vaidya, K. S., & Welch, D. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3559 · Cited by 411
Expression of MicroRNA‐146a in osteoarthritis cartilage
Yamasaki, K., Nakasa, T., Miyaki, S., Ishikawa, M., Deie, M., Adachi, N., Yasunaga, Y., Asahara, H., & Ochi, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24404 · Cited by 402
Loss of mir-146a function in hormone-refractory prostate cancer
Lin, S.-L., Chiang, A., Chang, D., & Ying, S.-Y. (2008) · RNA · doi:10.1261/rna.874808 · Cited by 382
Genetic susceptibility to breast cancer
Mavaddat, N., Antoniou, A. C., Easton, D. F., & Garcia-Closas, M. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.011 · Cited by 375
Growth retardation and tumour inhibition by BRCA1
Holt, J. T., Thompson, M. E., Szabo, C., Robinson-Benion, C., Arteaga, C. L., King, M.-C., & Jensen, R. A. (1996) · Nature Genetics · doi:10.1038/ng0396-298 · Cited by 361
Catteau, A., Harris, W. H., Xu, C.-F., & Solomon, E. (1999) · Oncogene · doi:10.1038/sj.onc.1202509 · Cited by 354
MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer
Dahiya, N., Sherman-Baust, C. A., Wang, T.-L., Davidson, B., Shih, I.-M., Zhang, Y., Wood, W., Becker, K. G., & Morin, P. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002436 · Cited by 352
A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis
Shen, J., Ambrosone, C. B., DiCioccio, R. A., Odunsi, K., Lele, S. B., & Zhao, H. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn172 · Cited by 347
Pogribny, I. P., Filkowski, J. N., Tryndyak, V. P., Golubov, A., Shpyleva, S. I., & Kovalchuk, O. (2010) · International Journal of Cancer · doi:10.1002/ijc.25191 · Cited by 334
BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
Elstrodt, F., Hollestelle, A., Nagel, J. H. A., Gorin, M., Wasielewski, M., van den Ouweland, A., Merajver, S. D., Ethier, S. P., & Schutte, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2853 · Cited by 305
MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence
Rusinov, V., Baev, V., Minkov, I. N., & Tabler, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki364 · Cited by 266
Curtale, G., Citarella, F., Carissimi, C., Goldoni, M., Carucci, N., Fulci, V., Franceschini, D., Meloni, F., Barnaba, V., & Macino, G. (2010) · Blood · doi:10.1182/blood-2009-06-225987 · Cited by 263
Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers
Lakhani, S. R., Manek, S., Penault-Llorca, F., Flanagan, A., Arnout, L., Merrett, S., McGuffog, L., Steele, D., Devilee, P., Klijn, J. G. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1029-3 · Cited by 252
Wyman, S. K., Parkin, R. K., Mitchell, P. S., Fritz, B. R., O'Briant, K., Godwin, A. K., Urban, N., Drescher, C. W., Knudsen, B. S., & Tewari, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005311 · Cited by 233
A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis
Labbaye, C., Spinello, I., Quaranta, M. T., Pelosi, E., Pasquini, L., Petrucci, E., Biffoni, M., Nuzzolo, E. R., Billi, M., Foà, R., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1741 · Cited by 229
Rice, J. C., Ozcelik, H., Maxeiner, P., Andrulis, I., & Futscher, B. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.9.1761 · Cited by 229
Abbott, D. W., Thompson, M. E., Robinson-Benion, C., Tomlinson, G., Jensen, R. A., & Holt, J. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18808 · Cited by 228
Role of miRNA-146a in the regulation of the innate immune response and cancer
Williams, A. E., Perry, M. M., Moschos, S. A., Larner-Svensson, H. M., & Lindsay, M. A. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361211 · Cited by 226
Beger, C., Pierce, L. N., Krüger, M., Marcusson, E. G., Robbins, J. M., Welcsh, P., Welch, P. J., Welte, K., King, M.-C., Barber, J. R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.130 · Cited by 221
Eitan, R., Kushnir, M., Lithwick-Yanai, G., David, M. B., Hoshen, M., Glezerman, M., Hod, M., Sabah, G., Rosenwald, S., & Levavi, H. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.04.024 · Cited by 161
BRCA1-associated growth arrest is RB-dependent
Aprelikova, O. N., Fang, B. S., Meissner, E. G., Cotter, S., Campbell, M., Kuthiala, A., Bessho, M., Jensen, R. A., & Liu, E. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11866 · Cited by 158
Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis.
Mialhe, A., Lafanéchère, L., Treilleux, I., Peloux, N., Dumontet, C., Bremond, A. G., Panh, M. H., Payan, R., Wehland, J., Margolis, R. L., et al. (2001) · PubMed · Cited by 157
Williams, F. M. K., & Spector, T. D. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2344 · Cited by 138
AKT1 Inhibits Homologous Recombination by Inducing Cytoplasmic Retention of BRCA1 and RAD51
Plo, I., Laulier, C., Gauthier, L., Lebrun, F., Calvo, F. M., & López, B. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0861 · Cited by 132
Regulation of BRCA1 expression and its relationship to sporadic breast cancer
Mueller, C. R., & Roskelley, C. D. (2002) · Breast Cancer Research · doi:10.1186/bcr557 · Cited by 128
Baldassarre, G., Battista, S., Belletti, B., Thakur, S., Pentimalli, F., Trapasso, F., Fedele, M., Pierantoni, G. M., Croce, C. M., & Fusco, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2225-2238.2003 · Cited by 128
Beckmann, M., Picard, F., An, H., van Roeyen, C. R. C., Dominik, S., Mosny, D., Schnürch, H.-G., Bender, H., & Niederacher, D. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.234 · Cited by 119
Anczuków, O., Ware, M. D., Buisson, M., Zetoune, A. B., Stoppa‐Lyonnet, D., Sinilnikova, O. M., & Mazoyer, S. (2007) · Human Mutation · doi:10.1002/humu.20590 · Cited by 108
Self-citationNuclear Factor-κB Contributes to Anaplastic Thyroid Carcinomas through Up-Regulation of miR-146a
Pacifico, F., Crescenzi, E., Mellone, S., Iannetti, A., Porrino, N., Liguoro, D., Moscato, F., Grieco, M., Formisano, S., & Leonardi, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1128 · Cited by 101
Weberpals, J. I., Clark-Knowles, K. V., & Vanderhyden, B. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3902 · Cited by 71
Dumay, A., Laulier, C., Bertrand, P., Saintigny, Y., Lebrun, F., Vayssière, J.-L., & López, B. S. (2005) · Oncogene · doi:10.1038/sj.onc.1209344 · Cited by 55
Self-citationDetailed deletion mapping of chromosome segment 17q12‐21 in sporadic breast tumours
Nagai, M. A., Yamamoto, L., Salaorni, S., Pacheco, M. M., Brentani, M. M., Barbosa, E. M., Brentani, H., Mazoyer, S., Smith, S. A., Ponder, B. A. J., et al. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110109 · Cited by 53
Self-citationJiménez, J. L., Mitchell, M., & SGOUROS, J. G. (2002) · Genome biology · doi:10.1186/gb-2002-4-1-r4 · Cited by 29
Cited by
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Kasinski, A. L., & Slack, F. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3166 · Cited by 936
van Schooneveld, E., Wildiers, H., Vergote, I., Vermeulen, P. B., Dirix, L. Y., & Van Laere, S. J. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0526-y · Cited by 296
MicroRNAs, new effectors and regulators of NF‐κB
Boldin, M. P., & Baltimore, D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01089.x · Cited by 199
Genomic integrity and the ageing brain
Chow, H.-M., & Herrup, K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4020 · Cited by 174
Metadata
- Authors
- Garcia, A. I., Buisson, M., Bertrand, P., Rimokh, R., Rouleau, E., Lopez, B. S., Lidereau, R., Mikaélian, I., & Mazoyer, S.
- Venue
- EMBO Molecular Medicine
- Published
- 2011-04-05
- Volume
- 3
- Issue
- 5
- Pages
- 279-290
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2156010403
- Cited by
- 265
- References
- 59
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.